chr10-13116262-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001008212.2(OPTN):​c.553-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 1,591,242 control chromosomes in the GnomAD database, including 519,174 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.81 ( 49925 hom., cov: 31)
Exomes 𝑓: 0.81 ( 469249 hom. )

Consequence

OPTN
NM_001008212.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00002316
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.120
Variant links:
Genes affected
OPTN (HGNC:17142): (optineurin) This gene encodes the coiled-coil containing protein optineurin. Optineurin may play a role in normal-tension glaucoma and adult-onset primary open angle glaucoma. Optineurin interacts with adenovirus E3-14.7K protein and may utilize tumor necrosis factor-alpha or Fas-ligand pathways to mediate apoptosis, inflammation or vasoconstriction. Optineurin may also function in cellular morphogenesis and membrane trafficking, vesicle trafficking, and transcription activation through its interactions with the RAB8, huntingtin, and transcription factor IIIA proteins. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-13116262-C-T is Benign according to our data. Variant chr10-13116262-C-T is described in ClinVar as [Benign]. Clinvar id is 197846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-13116262-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.854 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPTNNM_001008212.2 linkc.553-5C>T splice_region_variant, intron_variant Intron 5 of 14 ENST00000378747.8 NP_001008213.1 Q96CV9-1
OPTNNM_001008211.1 linkc.553-5C>T splice_region_variant, intron_variant Intron 6 of 15 NP_001008212.1 Q96CV9-1
OPTNNM_001008213.1 linkc.553-5C>T splice_region_variant, intron_variant Intron 6 of 15 NP_001008214.1 Q96CV9-1
OPTNNM_021980.4 linkc.553-5C>T splice_region_variant, intron_variant Intron 4 of 13 NP_068815.2 Q96CV9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPTNENST00000378747.8 linkc.553-5C>T splice_region_variant, intron_variant Intron 5 of 14 1 NM_001008212.2 ENSP00000368021.3 Q96CV9-1

Frequencies

GnomAD3 genomes
AF:
0.809
AC:
122848
AN:
151910
Hom.:
49876
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.810
Gnomad AMI
AF:
0.766
Gnomad AMR
AF:
0.866
Gnomad ASJ
AF:
0.908
Gnomad EAS
AF:
0.741
Gnomad SAS
AF:
0.808
Gnomad FIN
AF:
0.709
Gnomad MID
AF:
0.943
Gnomad NFE
AF:
0.810
Gnomad OTH
AF:
0.849
GnomAD3 exomes
AF:
0.817
AC:
205038
AN:
251040
Hom.:
84193
AF XY:
0.817
AC XY:
110911
AN XY:
135720
show subpopulations
Gnomad AFR exome
AF:
0.805
Gnomad AMR exome
AF:
0.880
Gnomad ASJ exome
AF:
0.917
Gnomad EAS exome
AF:
0.742
Gnomad SAS exome
AF:
0.826
Gnomad FIN exome
AF:
0.716
Gnomad NFE exome
AF:
0.818
Gnomad OTH exome
AF:
0.843
GnomAD4 exome
AF:
0.806
AC:
1160698
AN:
1439214
Hom.:
469249
Cov.:
28
AF XY:
0.808
AC XY:
579451
AN XY:
717342
show subpopulations
Gnomad4 AFR exome
AF:
0.803
Gnomad4 AMR exome
AF:
0.879
Gnomad4 ASJ exome
AF:
0.912
Gnomad4 EAS exome
AF:
0.726
Gnomad4 SAS exome
AF:
0.827
Gnomad4 FIN exome
AF:
0.722
Gnomad4 NFE exome
AF:
0.805
Gnomad4 OTH exome
AF:
0.823
GnomAD4 genome
AF:
0.809
AC:
122954
AN:
152028
Hom.:
49925
Cov.:
31
AF XY:
0.805
AC XY:
59809
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.810
Gnomad4 AMR
AF:
0.866
Gnomad4 ASJ
AF:
0.908
Gnomad4 EAS
AF:
0.741
Gnomad4 SAS
AF:
0.807
Gnomad4 FIN
AF:
0.709
Gnomad4 NFE
AF:
0.809
Gnomad4 OTH
AF:
0.850
Alfa
AF:
0.824
Hom.:
121330
Bravo
AF:
0.823
Asia WGS
AF:
0.795
AC:
2766
AN:
3478
EpiCase
AF:
0.831
EpiControl
AF:
0.831

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
May 08, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 21, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 15312511) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Primary open angle glaucoma Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Amyotrophic lateral sclerosis type 12 Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Primary open angle glaucoma;C1842026:Glaucoma 1, open angle, E;C3150692:Amyotrophic lateral sclerosis type 12 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.8
DANN
Benign
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000023
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2244380; hg19: chr10-13158262; COSMIC: COSV53814027; COSMIC: COSV53814027; API